ACCENTIA BIOPHARMACEUTICALS's ticker is ABPI and the CUSIP is 00430L103. A total of 3 filers reported holding ACCENTIA BIOPHARMACEUTICALS in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $0 | – | 16,874 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 16,874 | 0.0% | 0.00% | – |
| Q3 2014 | $25,000 | -62.1% | 16,874 | 0.0% | 0.00% | – |
| Q2 2014 | $66,000 | -51.1% | 16,874 | 0.0% | 0.00% | – |
| Q1 2014 | $135,000 | +187.2% | 16,874 | 0.0% | 0.00% | – |
| Q4 2013 | $47,000 | -44.0% | 16,874 | 0.0% | 0.00% | – |
| Q3 2013 | $84,000 | -57.4% | 16,874 | 0.0% | 0.00% | – |
| Q2 2013 | $197,000 | – | 16,874 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CENTRAL TRUST Co | 7,375 | $0 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 15,000 | $0 | 0.00% |
| Highlander Capital Management, LLC | 16,874 | $0 | 0.00% |